Cited by 151Neuroinflammation and Neurodegeneration MechanismsGenetic Neurodegenerative DiseasesNeurological Disease Mechanisms and Treatments

The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.

Microglial activation in the pathogenesis of Huntington's disease

Open access

Yang, Hui-Ming, Yang, Su, Huang, Shan-Shan, Tang, Bei-Sha, Guo, Ji-Feng·2017·Frontiers in Aging Neuroscience

DOI 10.3389/fnagi.2017.00193PMC PMC5474461

Open this paper in CoChat — free account Open PDF

Abstract

gene that encodes huntingtin protein. Although HD is characterized by a predominant loss of neurons in the striatum and cortex, previous studies point to a critical role of aberrant accumulation of mutant huntingtin in microglia that contributes to the progressive neurodegeneration in HD, through both cell-autonomous and non-cell-autonomous mechanisms. Microglia are resident immune cells in the central nervous system (CNS), which function to surveil the microenvironment at a quiescent state. In response to various pro-inflammatory stimuli, microglia become activated and undergo two separate phases (M1 and M2 phenotype), which release pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α), anti-inflammatory cytokines, and growth factors (TGF-β, CD206, and Arg1), respectively. Immunoregulation by microglial activation could be either neurotoxic or neuroprotective. In this review, we summarized current understanding about microglial activation in the pathogenesis and progression of HD, with a primary focus of M1 and M2 phenotype of activated microglia and their corresponding signaling pathways.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.3389/fnagi.2017.00193

Cites

118 of 118 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144
Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity
Polazzi, E., Mengoni, I., Caprini, M., Peña‐Altamira, E., Kurtys, E., & Monti, B. (2012) · Neurosignals · doi:10.1159/000337115 · Cited by 9,023
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971 · cited 1×
“However, a recent study revealed that neurotoxic reactive astrocytes could be induced by activated microglia and consequently resulted in a similar expression proﬁle of pro-inﬂammatory cytokines, which led to a more rapid death of neurons and oligodendrocytes (Liddelow et al., 2017).”
Background
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
Microglia: Active sensor and versatile effector cells in the normal and pathologic brain
Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638
Multiple Wearable Sensors in Parkinson and Huntington Disease Individuals: A Pilot Study in Clinic and at Home
Adams, J., Dinesh, K., Xiong, M., Tarolli, C. G., Sharma, S., Sheth, N., Aranyosi, A. J., Zhu, W. Y., Goldenthal, S. B., Biglan, K., et al. (2017) · Digital Biomarkers · doi:10.1159/000479018 · Cited by 3,190
Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
TLR signaling pathways
Takeda, K., & Akira, S. (2004) · Seminars in Immunology · doi:10.1016/j.smim.2003.10.003 · Cited by 2,528

Show all 118 references

Sorted by citations

Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets
Gao, C., Jiang, J., Tan, Y., & Chen, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01588-0 · Cited by 1,616
The blood-brain barrier in aging and neurodegeneration
Knox, E. G., Aburto, M. R., Clarke, G., Cryan, J. F., & O’Driscoll, C. M. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01511-z · Cited by 738
The Role of Microglia in Diabetic Retinopathy: Inflammation, Microvasculature Defects and Neurodegeneration
Altmann, C., & Schmidt, M. H. H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010110 · Cited by 413
The Role of Microglia and Astrocytes in Huntington’s Disease
Palpagama, T. H., Waldvogel, H. J., Faull, R. L. M., & Kwakowsky, A. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00258 · Cited by 246
Neurodegenerative Diseases: Regenerative Mechanisms and Novel Therapeutic Approaches
Hussain, R., Zubair, H., Sarah, P., & Shahab, M. (2018) · Brain Sciences · doi:10.3390/brainsci8090177 · Cited by 244
CX3CL1/CX3CR1 signaling targets for the treatment of neurodegenerative diseases
Subbarayan, M. S., Joly‐Amado, A., Bickford, P. C., & Nash, K. R. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107989 · Cited by 204
Maternal immune activation in neurodevelopmental disorders
Solek, C. M., Farooqi, N., Verly, M., Lim, T. K., & Ruthazer, E. S. (2018) · Developmental Dynamics · doi:10.1002/dvdy.24612 · Cited by 168
Inhibition of colony stimulating factor-1 receptor (CSF-1R) as a potential therapeutic strategy for neurodegenerative diseases: opportunities and challenges
Han, J., Chiţu, V., Stanley, E. R., Wszołek, Z. K., Karrenbauer, V. D., & Harris, R. A. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04225-1 · Cited by 169
The World Goes Bats: Living Longer and Tolerating Viruses
Gorbunova, V., Seluanov, A., & Kennedy, B. K. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.06.013 · Cited by 162
From Pathogenesis to Therapeutics: A Review of 150 Years of Huntington’s Disease Research
Jiang, A., Handley, R. R., Lehnert, K., & Snell, R. G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241613021 · Cited by 174
Microglial depletion prevents extracellular matrix changes and striatal volume reduction in a model of Huntington's disease
Crapser, J. D., Ochaba, J., Soni, N., Reidling, J. C., Thompson, L. M., & Green, K. N. (2020) · Brain · doi:10.1093/brain/awz363 · Cited by 157
Dysregulated phosphoinositide 3-kinase signaling in microglia: shaping chronic neuroinflammation
Chu, E., Mychasiuk, R., Hibbs, M. L., & Semple, B. D. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02325-6 · Cited by 152
Heat-Shock Proteins in Neuroinflammation
Dukay, B., Csoboz, B., & Tóth, M. E. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00920 · Cited by 139
Enforced microglial depletion and repopulation as a promising strategy for the treatment of neurological disorders
Han, J., Zhu, K., Zhang, X., & Harris, R. A. (2018) · Glia · doi:10.1002/glia.23529 · Cited by 116
Molecular hydrogen attenuates sepsis-induced neuroinflammation through regulation of microglia polarization through an mTOR-autophagy-dependent pathway
Zhuang, X., Yu, Y., Jiang, Y., Zhao, S., Wang, Y., Su, L., Xie, K., Yu, Y., Lu, Y., & Lv, G. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106287 · Cited by 115
Targeting the NLRP3 Inflammasome-Related Pathways via Tianeptine Treatment-Suppressed Microglia Polarization to the M1 Phenotype in Lipopolysaccharide-Stimulated Cultures
Ślusarczyk, J., Trojan, E., Głombik, K., Piotrowska, A., Budziszewska, B., Kubera, M., Popiołek-Barczyk, K., Lasoń, W., Mika, J., & Basta‐Kaim, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071965 · Cited by 110
Molecular Pathophysiological Mechanisms in Huntington’s Disease
Jurcău, A. (2022) · Biomedicines · doi:10.3390/biomedicines10061432 · Cited by 118
New Insights into Oxidative Stress and Inflammatory Response in Neurodegenerative Diseases
Scarian, E., Viola, C., Dragoni, F., Gerlando, R. D., Rizzo, B., Diamanti, L., Gagliardi, S., Bordoni, M., & Pansarasa, O. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052698 · Cited by 118
Natural Products as a Potential Modulator of Microglial Polarization in Neurodegenerative Diseases
Jin, X., Liu, M.-Y., Zhang, D.-F., Zhong, X., Du, K., Qian, P., Gao, H., & Wei, M.-J. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104253 · Cited by 109
Inflammatory resolution and vascular barrier restoration after retinal ischemia reperfusion injury
Abcouwer, S. F., Shanmugam, S., Muthusamy, A., Lin, C., Kong, D., Hager, H. M., Liu, X., & Antonetti, D. A. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02237-5 · Cited by 108
The dual face of microglia (M1/M2) as a potential target in the protective effect of nutraceuticals against neurodegenerative diseases
Darwish, S. F., Elbadry, A. M. M., Elbokhomy, A. S., Salama, G. A., & Salama, R. M. (2023) · Frontiers in Aging · doi:10.3389/fragi.2023.1231706 · Cited by 110
Microglial physiological properties and interactions with synapses are altered at presymptomatic stages in a mouse model of Huntington’s disease pathology
Savage, J. C., St‐Pierre, M., Carrier, M., Hajj, H. E., Novak, S. W., Sánchez, M. G., Cicchetti, F., & Tremblay, M. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01782-9 · Cited by 103
Microglia-derived IL-1β promoted neuronal apoptosis through ER stress-mediated signaling pathway PERK/eIF2α/ATF4/CHOP upon arsenic exposure
Liu, X., Chen, Y., Wang, H., Wei, Y., Yuan, Y., Zhou, Q., Fang, F., Shi, S., Jiang, X., Dong, Y., et al. (2021) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2021.125997 · Cited by 102
Review on Cross Talk between Neurotransmitters and Neuroinflammation in Striatum and Cerebellum in the Mediation of Motor Behaviour
Wahab, D. Y. A. A., Gau, C. H., Zakaria, R., Karuppan, M. K. M., Al-Rahbi, B. S., Abdullah, Z., Alrafiah, A., Abdullah, J. M., & Muthuraju, S. (2019) · BioMed Research International · doi:10.1155/2019/1767203 · Cited by 94
Fueling neurodegeneration: metabolic insights into microglia functions
Sadeghdoust, M., Das, A., & Kaushik, D. K. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03296-0 · Cited by 107
Adipose tissue, systematic inflammation, and neurodegenerative diseases
Migliolo, L., Boleti, A. P. D. A., Cardoso, P. H. D. O., Frihling, B. E. F., Silva, P. S. E., & de Moraes, L. F. R. N. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.343891 · Cited by 94
Glia in neurodegeneration: Drivers of disease or along for the ride?
Gleichman, A. J., & Carmichael, S. T. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104957 · Cited by 90
MiR-124 and the Underlying Therapeutic Promise of Neurodegenerative Disorders
Han, D., Dong, X., Zheng, D., & Nao, J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01555 · Cited by 90
Intranasal Administration of Mesenchymal Stem Cells Ameliorates the Abnormal Dopamine Transmission System and Inflammatory Reaction in the R6/2 Mouse Model of Huntington Disease
Yu-Taeger, L., Stricker-Shaver, J., Arnold, K., Bambynek-Dziuk, P., Novati, A., Singer, E., Lourhmati, A., Fabian, C., Magg, J. C. D., Rieß, O., et al. (2019) · Cells · doi:10.3390/cells8060595 · Cited by 76
Altered Cholesterol Homeostasis in Huntington’s Disease
Kacher, R., Mounier, C., Caboche, J., & Bétuing, S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.797220 · Cited by 74
Astrocytes and microglia in neurodegenerative diseases: Lessons from human in vitro models
Franklin, H., Clarke, B. E., & Patani, R. (2021) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101973 · Cited by 66
miR-124-3p attenuates MPP + -induced neuronal injury by targeting STAT3 in SH-SY5Y cells
Geng, L., Liu, W., & Chen, Y. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217734492 · Cited by 63
Microglia alterations in neurodegenerative diseases and their modeling with human induced pluripotent stem cell and other platforms
Sabogal-Guáqueta, A. M., Marmolejo-Garza, A., de Pádua, V. P., Eggen, B. J. L., Boddeke, E., & Dolga, A. M. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101805 · Cited by 65
Potential anti-neuroinflammatory NF-кB inhibitors based on 3,4-dihydronaphthalen-1(2H)-one derivatives
Sun, Y. M., Zhou, Y.-Q., Liu, Y.-K., Zhang, H., Hou, G., Meng, Q., & Hou, Y. (2020) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2020.1804899 · Cited by 60
Microglial response to aging and neuroinflammation in the development of neurodegenerative diseases
Han, T., Xu, Y., Sun, L., Hashimoto, M., & Wei, J. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.385845 · Cited by 64
Innate sensing of mechanical properties of brain tissue by microglia
Ayata, P., & Schaefer, A. (2020) · Current Opinion in Immunology · doi:10.1016/j.coi.2020.01.003 · Cited by 57
Conditioned medium from amniotic cells protects striatal degeneration and ameliorates motor deficits in the R6/2 mouse model of Huntington's disease
Giampà, C., Alvino, A., Magatti, M., Silini, A. R., Cardinale, A., Paldino, E., Fusco, F. R., & Parolini, O. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14113 · Cited by 57
The role of mitochondrial dysfunction in Huntington’s disease: Implications for therapeutic targeting
Joshi, D. C., Chavan, M. B., Gurow, K., Gupta, M., Dhaliwal, J. S., & Ming, L. C. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.117827 · Cited by 62
Histamine Induces Microglia Activation and the Release of Proinflammatory Mediators in Rat Brain Via H1R or H4R
Zhang, W., Zhang, X., Zhang, Y., Qu, C., Zhou, X., & Zhang, S. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09887-6 · Cited by 57
MiR-145 enriched exosomes derived from bone marrow-derived mesenchymal stem cells protects against cerebral ischemia-reperfusion injury through downregulation of FOXO1
Zhou, H., Zhou, J., Teng, H., Yang, H., Qiu, J., & Li, X. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.09.089 · Cited by 50
Self-citation
The Role of IL-6 in Neurodegenerative Disorders
Shan, C., Zhang, C., & Zhang, C. (2024) · Neurochemical Research · doi:10.1007/s11064-023-04085-6 · Cited by 52
Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential
Vuić, B., Milos, T., Tudor, L., Konjevod, M., Perković, M. N., Jembrek, M. J., Erjavec, G. N., & Štrac, D. Š. (2022) · Biomedicines · doi:10.3390/biomedicines10123000 · Cited by 49
Reduced Fractalkine Levels Lead to Striatal Synaptic Plasticity Deficits in Huntington’s Disease
Kim, A. A., García-García, E., Straccia, M., Comella-Bolla, A., Miguez, A., Masana, M., Alberch, J., Canals, J. M., & Rodríguez, M. J. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00163 · Cited by 47
Neuroimmunometabolism: A New Pathological Nexus Underlying Neurodegenerative Disorders
Mitra, S., Banik, A., Saurabh, S., Maulik, M., & Khatri, S. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.0998-21.2022 · Cited by 45
TSPO–PET imaging using [18F]PBR06 is a potential translatable biomarker for treatment response in Huntington’s disease: preclinical evidence with the p75NTR ligand LM11A-31
Simmons, D. A., James, M. L., Belichenko, N. P., Semaan, S., Condon, C., Kuan, J., Shuhendler, A. J., Miao, Z., Chin, F. T., & Longo, F. M. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy202 · Cited by 44
LncRNA HOTAIR Participates in Microglia Activation and Inflammatory Factor Release by Regulating the Ubiquitination of MYD88 in Traumatic Brain Injury
Cheng, S., Zhang, Y., Chen, S., & Zhou, Y.-L. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01623-7 · Cited by 44
Neurodegenerative Diseases: Unraveling the Heterogeneity of Astrocytes
Santiago-Balmaseda, A., Aguirre-Orozco, A., Valenzuela-Arzeta, I. E., Villegas-Rojas, M. M., Pérez‐Segura, I., Jiménez-Barrios, N., Hurtado-Robles, E., Rodríguez-Hernández, L. D., Rivera-German, E. R., Guerra‐Crespo, M., et al. (2024) · Cells · doi:10.3390/cells13110921 · Cited by 43
Genetic topography and cortical cell loss in Huntington's disease link development and neurodegeneration
Estevez‐Fraga, C., Altmann, A., Parker, C. S., Scahill, R. I., Costa, B., Chen, Z., Manzoni, C., Zarkali, A., Dürr, A., Roos, R. A. C., et al. (2023) · Brain · doi:10.1093/brain/awad275 · Cited by 41
RNA Sequencing Reveals Small and Variable Contributions of Infectious Agents to Transcriptomes of Postmortem Nervous Tissues From Amyotrophic Lateral Sclerosis, Alzheimer’s Disease and Parkinson’s Disease Subjects, and Increased Expression of Genes From Disease-Activated Microglia
Bennett, J. P., Keeney, P. M., & Brohawn, D. G. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00235 · Cited by 38
Utilising Induced Pluripotent Stem Cells in Neurodegenerative Disease Research: Focus on Glia
Albert, K., Niskanen, J., Kälvälä, S., & Lehtonen, Š. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094334 · Cited by 40
Lack of RAN-mediated toxicity in Huntington’s disease knock-in mice
Yang, S., Yang, H., Huang, L., Chen, L., Qin, Z. S., Li, S., & Li, X. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1919197117 · Cited by 37
Self-citation
Allele-specific genome targeting in the development of precision medicine
Wu, J., Tang, B., & Tang, Y. (2020) · Theranostics · doi:10.7150/thno.43298 · Cited by 43
Self-citation
Neuroimmune crosstalk and evolving pharmacotherapies in neurodegenerative diseases
Baidya, F., Bohra, M., Datta, A., Sarmah, D., Shah, B., Jagtap, P., Raut, S., Sarkar, A., Singh, U., Kalia, K., et al. (2020) · Immunology · doi:10.1111/imm.13264 · Cited by 39
Parthenolide ameliorates 3-nitropropionic acid-induced Huntington’s disease-like aberrations via modulating NLRP3 inflammasome, reducing microglial activation and inducing astrocyte shifting
Noureldeen, M. E., Shahin, N. N., Amin, H. A. A., El‐Sawalhi, M. M., & Ghaiad, H. R. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00917-5 · Cited by 37
Epigenetic Modulation of Microglia Function and Phenotypes in Neurodegenerative Diseases
Wang, L., Yu, C.-C., Liu, X., Deng, X., Tian, Q., & Du, Y. (2021) · Neural Plasticity · doi:10.1155/2021/9912686 · Cited by 41
Neuroinflammation and histone H3 citrullination are increased in X-linked Dystonia Parkinsonism post-mortem prefrontal cortex
Petrozziello, T., Mills, A. N., Vaine, C. A., Penney, E. B., Fernandez‐Cerado, C., Legarda, G. P., Velasco-Andrada, M. S., Acuña, P. J., Ang, M. A. C., Muñoz, E. L., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105032 · Cited by 35
Huntington disease: somatic expansion, pathobiology and therapeutics
Donaldson, J., Moss, D. J. H., Ciosi, M., Usdin, K., Balmus, G., Monckton, D. G., & Tabrizi, S. J. (2025) · Nature Reviews Neurology · doi:10.1038/s41582-025-01159-7 · Cited by 36
Therapeutic Strategies in Huntington’s Disease: From Genetic Defect to Gene Therapy
Jurcău, A., & Jurcău, M. C. (2022) · Biomedicines · doi:10.3390/biomedicines10081895 · Cited by 37
Phosphoinositides: Roles in the Development of Microglial-Mediated Neuroinflammation and Neurodegeneration
Ernest James Phillips, T., & Maguire, E. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.652593 · Cited by 33
The Cytokine CX3CL1 and ADAMs/MMPs in Concerted Cross-Talk Influencing Neurodegenerative Diseases
Iemmolo, M., Ghersi, G., & Bivona, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098026 · Cited by 35
IKKβ slows Huntington’s disease progression in R6/1 mice
Ochaba, J., Fote, G., Kachemov, M., Thein, S. H., Yeung, S. Y., Lau, A., Hernandez, S. J., Lim, R. G., Casale, M., Neel, M. J., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814246116 · Cited by 31
Recent developments in the management of Huntington's disease
Devadiga, S., & Bharate, S. S. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.105642 · Cited by 36
Towards a comprehensive understanding of the contributions of mitochondrial dysfunction and oxidative stress in the pathogenesis and pathophysiology of Huntington's disease
Tobore, T. O. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24492 · Cited by 32
Heterogeneity of Microglia Phenotypes: Developmental, Functional and Some Therapeutic Considerations
Yuan, Y., Wu, C., & Ling, E. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190722114248 · Cited by 31
Stearoylethanolamide interferes with retrograde endocannabinoid signalling and supports the blood-brain barrier integrity under acute systemic inflammation
Kasatkina, L. A., Heinemann, Á., Hudz, Y. A., Thomas, D., & Sturm, E. M. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113783 · Cited by 30
Toll-like Receptors as a Novel Therapeutic Target for Natural Products Against Chronic Diseases
Narayanankutty, A. (2019) · Current Drug Targets · doi:10.2174/1389450120666190222181506 · Cited by 29
YY1 PROMOTES MICROGLIA M2 POLARIZATION THROUGH THE MIR-130A-3P/TREM-2 AXIS TO ALLEVIATE SEPSIS-ASSOCIATED ENCEPHALOPATHY
Peng, L.-S., Xu, Y., & Wang, Q.-S. (2022) · Shock · doi:10.1097/shk.0000000000001914 · Cited by 28
The longevity-associated variant of BPIFB4 improves a CXCR4-mediated striatum–microglia crosstalk preventing disease progression in a mouse model of Huntington’s disease
Pardo, A. D., Ciaglia, E., Cattaneo, M., Maciag, A. E., Montella, F., Lopardo, V., Ferrario, A., Villa, F., Madonna, M., Amico, E., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02754-w · Cited by 28
Roles of Fatty Acids in Microglial Polarization: Evidence from In Vitro and In Vivo Studies on Neurodegenerative Diseases
Sanjay, S., Park, M., & Lee, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137300 · Cited by 28
Perspective of Molecular Hydrogen in the Treatment of Sepsis
Qi, B., Yu, Y., Wang, Y., Wang, Y., Yu, Y., & Xie, K. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200909124936 · Cited by 25
Integrated multi-omics analysis of Huntington disease identifies pathways that modulate protein aggregation
Pradhan, S. S., Manohar, T. S., Saiswaroop, R., Bhagavatham, S. K. S., Pulukool, S. K., Rathnakumar, S., Kanikaram, S. P., Dandamudi, R. B., Pargaonkar, A., Joseph, P., et al. (2022) · Disease Models & Mechanisms · doi:10.1242/dmm.049492 · Cited by 25
The updated development of blood-based biomarkers for Huntington’s disease
Zhang, S., Cheng, Y., & Shang, H. (2023) · Journal of Neurology · doi:10.1007/s00415-023-11572-x · Cited by 28
Nicotinic acetylcholine receptors: Key targets for attenuating neurodegenerative diseases
Bye, L. J., Finol‐Urdaneta, R. K., Tae, H., & Adams, D. J. (2023) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2023.106387 · Cited by 28
Peroxisom proliferator-activated receptor-γ coactivator-1α in neurodegenerative disorders: A promising therapeutic target
Yang, Y.-N., Zhang, M.-Q., Yu, F.-L., Han, B., Bao, M.-Y., Yan-He, Yan-he, & Zhang, Y. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115717 · Cited by 26
Bilateral quinolinic acid‐induced lipid peroxidation, decreased striatal monoamine levels and neurobehavioral deficits are ameliorated by GIP receptor agonist D‐Ala2GIP in rat model of Huntington's disease
Verma, M. K., Goel, R., Nandakumar, K., & Nemmani, K. V. S. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.03.034 · Cited by 22
Neuroinflammation and neurodegeneration in Huntington’s disease: genetic hallmarks, role of metals and organophosphates
Kuwar, O. K., & Singh, S. (2025) · Neurogenetics · doi:10.1007/s10048-025-00801-2 · Cited by 26
Hydroxysafflor Yellow A Exerts Anti-Inflammatory Effects Mediated by SIRT1 in Lipopolysaccharide-Induced Microglia Activation
Qin, X., Chen, J., Zhang, G., Li, C., Zhu, J., Xue, H., Li, J., Guan, T., Zheng, H., Liu, Y., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01315 · Cited by 23
Hierarchical deconvolution for extensive cell type resolution in the human brain using DNA methylation
Zhang, Z., Wiencke, J. K., Kelsey, K. T., Koestler, D. C., Molinaro, A. M., Pike, S. C., Karra, P., Christensen, B. C., & Salas, L. A. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1198243 · Cited by 23
Reduction in GABAB on glia induce Alzheimer’s disease related changes
Osse, A. M. L., Pandey, R. S., Wirt, R. A., Ortiz, A. A., Salazar, A., Kimmich, M. J., Strom, E. N. T., Oblak, A. L., Lamb, B. T., Hyman, J. M., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.03.002 · Cited by 21
TYROBP/DAP12 knockout in Huntington’s disease Q175 mice cell-autonomously decreases microglial expression of disease-associated genes and non-cell-autonomously mitigates astrogliosis and motor deterioration
Creus‐Muncunill, J., Haure‐Mirande, J., Mattei, D., Bons, J., Jimenez, A. V. R., Hamilton, B. W., Corwin, C., Chowdhury, S., Schilling, B., Ellerby, L., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03052-4 · Cited by 21
Emerging roles of cannabinoid receptor CB2 receptor in the central nervous system: therapeutic target for CNS disorders
Bala, K., Porel, P., & Aran, K. R. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06683-w · Cited by 18
Discovery of anti-neuroinflammatory agents from 1,4,5,6-tetrahydrobenzo[2,3]oxepino[4,5-d]pyrimidin-2-amine derivatives by regulating microglia polarization
Yang, Y., Gao, Z., Hou, G., Meng, Q., & Hou, Y. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115688 · Cited by 18
Inflammatory changes in peripheral organs in the BACHD murine model of Huntington's disease
Valadão, P. A. C., Oliveira, B. D. S., Joviano‐Santos, J. V., Vieira, É. L. M., Rocha, N. P., Teixeira, A. L., Guatimosim, C., & de Miranda, A. S. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116653 · Cited by 18
Neuro‐Immune Crosstalk: Molecular Mechanisms, Biological Functions, Diseases, and Therapeutic Targets
Guo, X., Liu, H. N., Song, Y., Wang, J., Liu, D., Zheng, Z., Li, J., Li, B., Song, A., He, W., et al. (2026) · MedComm · doi:10.1002/mco2.70497 · Cited by 26
Age-related mitochondrial alterations in brain and skeletal muscle of the YAC128 model of Huntington disease
Bečanović, K., Asghar, M., Gadawska, I., Sachdeva, S., Walker, D., Lazarowski, E. R., Franciosi, S., Park, K. H. J., Côté, H. C. F., & Leavitt, B. R. (2021) · npj Aging and Mechanisms of Disease · doi:10.1038/s41514-021-00079-2 · Cited by 18
Implications of VIP and PACAP in Parkinson’s Disease: What do we Know So Far?
Resende, F., Ribeiro, F. M., & Lima, P. M. D. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200320162436 · Cited by 17
Microglial exosomes in paraquat-induced Parkinson's disease: Neuroprotection and biomarker clues
Wu, J., Shao, W., Liu, X., Zheng, F., Wang, Y., Cai, P., Guo, Z., Hu, H., Yu, G., Guo, J., et al. (2024) · Environmental Pollution · doi:10.1016/j.envpol.2024.124035 · Cited by 16
Self-citation
The role of multimodal MRI in mild cognitive impairment and Alzheimer's disease
Knudsen, L. V., Gazerani, P., Duan, Y., Michel, T. M., & Vafaee, M. S. (2021) · Journal of Neuroimaging · doi:10.1111/jon.12940 · Cited by 16
Advances in Stem Cell Therapy for Huntington’s Disease: A Comprehensive Literature Review
Shah, S., Mansour, H. M., & Lucke-Wold, B. P. (2025) · Cells · doi:10.3390/cells14010042 · Cited by 16
Advances in nanotherapeutic strategies for Huntington's disease: Design, delivery, and neuroprotective mechanisms
Khan, S., Bano, N., Ahamad, S., Dar, N. J., Nazir, A., & Bhat, S. A. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2024.216206 · Cited by 14
Arsenic exposure activates microglia, inducing neuroinflammation and promoting the occurrence and development of Alzheimer's disease-like neurodegeneration in mice
Zhang, B., Wang, J., Chen, J., & Pan, X. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.118251 · Cited by 12
Micrandilactone C, a Nortriterpenoid Isolated from Roots of Schisandra chinensis, Ameliorates Huntington’s Disease by Inhibiting Microglial STAT3 Pathways
Jang, M., Choi, J. H., Jang, D. S., & Cho, I. (2023) · Cells · doi:10.3390/cells12050786 · Cited by 12
Non-Cell Autonomous and Epigenetic Mechanisms of Huntington’s Disease
Kim, C., Yousefian-Jazi, A., Choi, S.-H., Chang, I., Lee, J.-H., & Ryu, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212499 · Cited by 13
Effect of Capsaicin on 3-NP-Induced Neurotoxicity: A Pre-Clinical Study
Tyagi, S., & Thakur, A. K. (2024) · Neurochemical Research · doi:10.1007/s11064-024-04158-0 · Cited by 10
Bacillus calmette gaurine vaccine ameliorates the neurotoxicity of quinolinic acid in rats via the modulation of antioxidant, inflammatory and apoptotic markers
Yedke, N. G., Arthur, R., & Kumar, P. (2023) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2023.102287 · Cited by 10
Redistribution of ASIC1a channels triggered by IL-6: Potential role of ASIC1a in neuroinflammation
Castellanos, L. C. S., Gatto, R. G., Malnati, G. O. M., Montes, M. M., Uchitel, O. D., & Weissmann, C. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166927 · Cited by 10
Therapeutic potential of thymoquinone and its nanoformulations in neuropsychological disorders: a comprehensive review on molecular mechanisms in preclinical studies
Saadat, M., Dahmardeh, N., Sheikhbahaei, F., & Mokhtari, T. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02832-8 · Cited by 9
A supercritical oil extract of Schisandra chinensis seeds ameliorates Huntington’s disease-like symptoms and neuropathology: the potential role of anti-oxidant and anti-inflammatory effects
Jo, H.-S., Lee, Y.-W., Son, S.-R., Jang, D. S., Kwon, T. W., Ha, Y., Moon, S., Kim, M. S., & Cho, I. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1471024 · Cited by 9
The microbiota-gut-brain axis in Huntington’s disease: Evidence, mechanisms and therapeutic opportunities
Gu, Y., Wang, M., & Mao, Y. (2026) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2026.101247 · Cited by 9
Mechanistic insights and therapeutic potential of targeting the cGAS–STING pathway in neurodegenerative diseases
Liu, H., Hu, C., Liu, H., Gong, Z., Jiang, S., Xie, J., Li, Y., Liu, C., Wang, Y., Zou, C., et al. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03815-1 · Cited by 9

Authors: Yang, H.-M., Yang, S., Huang, S.-S., Tang, B.-S., & Guo, J.-F.
Affiliations: Emory University (US)
ORCID: Yang, Su
Venue: Frontiers in Aging Neuroscience
Publisher: Frontiers Media SA
Published: 2017-06-19
Volume: 9
Pages: 193-193
ISSN: 1663-4365 (ISSN-L)
DOI: 10.3389/fnagi.2017.00193
PMC: PMC5474461
OpenAlex: W2625794193
Cited by: 151
References: 118
Citations by year: 2026: 20 · 2025: 15 · 2024: 19 · 2023: 16 · 2022: 16 · 2021: 17 · 2020: 21 · 2019: 17 · 2018: 7 · 2017: 2
FWCI: 1.23
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
Locations: Frontiers in Aging Neuroscience (publishedVersion, cc-by)
Europe PMC (PubMed Central) (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders: National Natural Science Foundation of China (81430023, 2016CX025, 2016YFC1306000, 81371405, 81571248)
Central South University (2016CX025)
Topics: Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords: Huntington's disease, microglial activation, mutant huntingtin, M1/M2 microglial polarization, neuroinflammation, inflammatory cytokines, anti-inflammatory cytokines, neurodegeneration, striatum, signaling pathways, neuroprotection

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Microglial activation in the pathogenesis of Huntington's disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks